Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jose Amores-Tirado"'
Autor:
Sandra Hervas-Stubbs, Ibon Tamayo-Uria, Pablo Sarobe, Uxua Mancheño, Antonio González-Martín, Edurne Elizalde, José Manuel Aramendía, Juan C. Muruzabal, Mariano Ponz-Sarvise, Francisco Guillén-Grima, Juan José Lasarte, Julia Alcaide, Enrique Conde, David Garcia-Ros, Carlos E. de Andrea, Diego Salas-Benito, José Ángel Mínguez, Jose Amores-Tirado
Publikováno v:
British Journal of Cancer
Background Adoptive immunotherapy with tumour-infiltrating lymphocytes (TIL) may benefit from the use of selective markers, such as PD-1, for tumour-specific T-cell enrichment, and the identification of predictive factors that help identify those pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8341aaeb56bee99355258a52e317e5a5
http://europepmc.org/articles/PMC7961070
http://europepmc.org/articles/PMC7961070
Autor:
Diego Salas-Benito, Enrique Conde, Ibon Tamayo-Uria, Uxua Mancheño, Edurne Elizalde, David Garcia-Ros, Jose M. Aramendia, Juan C. Muruzabal, Julia Alcaide, Francisco Guillen-Grima, Jose A. Minguez, Jose Amores-Tirado, Antonio Gonzalez-Martin, Pablo Sarobe, Juan J. Lasarte, Mariano Ponz-Sarvise, Carlos E. De Andrea, Sandra Hervas-Stubbs
Background: Adoptive immunotherapy with tumor-infiltrating lymphocytes (TIL) may benefit from the use of selective markers, such as programmed cell death protein 1 (PD-1), for tumor-specific T-cell enrichment, as well as predictive biomarkers that he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7ec119d7cf271d8c737de45bd71cc08
https://doi.org/10.21203/rs.3.rs-25670/v1
https://doi.org/10.21203/rs.3.rs-25670/v1
